c-erbB-2 in breast cancer: Development of a clinically useful marker
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (3) , 231-245
- https://doi.org/10.1053/sonc.2002.32899
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*Journal of Clinical Oncology, 2001
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- Prognostic Factors in Breast Cancer: Current and New Predictors of MetastasisJournal of Mammary Gland Biology and Neoplasia, 2001
- Prognostic Factors in Breast CancerArchives of Pathology & Laboratory Medicine, 2000
- Do we need prognostic factors in nodal-negative breast cancer?: Arbiter:European Journal Of Cancer, 2000
- Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?Breast Cancer Research and Treatment, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor MarkersJNCI Journal of the National Cancer Institute, 1996